Women with hereditary breast cancer could be cured of the disease by taking daily pills, a major study has found. A revolutionary drug called Olaparib was found to slash the chance of breast cancer returning or spreading in women with the faulty BRCA gene by up to 42 per cent. Professor Paul Workman, chief executive of The Institute of Cancer Research, said: 'Olaparib was the first cancer drug in the world to target inherited genetic faults. 'It is also now the first targeted drug to have been shown to effectively treat patients with inherited mutations and early-stage breast cancer. The trial involved 831 patients and was led by an international group including the Institute of Cancer Research in London.

Source: Daily Mail June 03, 2021 22:33 UTC